WARREN, N.J., Oct. 1, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the FDA has accepted for filing the New Drug Application (NDA) of sepiapterin for the treatment of ...
The approval came days before the FDA’s expected deadline and makes this the only PD-1 inhibitor approved for resectable ...
The Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for sepiapterin as a treatment for pediatric and adult patients living with phenylketonuria (PKU).
Joshua Wallace is seeking to become chief of the Des Moines Police Department. In February, he went bankrupt, reporting a ...
"The FDA filing acceptance for sepiapterin is a critical milestone toward bringing this potential important therapy to children and adults living with PKU in the United States," said PTC ...
WARREN, N.J., Oct. 1, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the FDA has accepted for filing the New Drug Application (NDA) of sepiapterin for the treatment of ...
That's because an FDA filing of this drug for the treatment of adult patients with IgA Nephropathy [IgAN] was accepted by the FDA based on a 36-week interim analysis of proteinuria reduction ...
LOS ANGELES (AP) — A San Diego doctor charged in connection with Matthew Perry ’s fatal overdose pleaded guilty Wednesday to ...
Septerna (SEPN), which is developing a treatment for hypoparathyroidism, has filed for a proposed $100M initial public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback